These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Erythropoietic response to anemia in chronic hepatitis C patients receiving combination pegylated interferon/ribavirin. Balan V, Schwartz D, Wu GY, Muir AJ, Ghalib R, Jackson J, Keeffe EB, Rossaro L, Burnett A, Goon BL, Bowers PJ, Leitz GJ, HCV Natural History Study Group. Am J Gastroenterol; 2005 Feb; 100(2):299-307. PubMed ID: 15667486 [Abstract] [Full Text] [Related]
24. The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism. Carella C, Mazziotti G, Morisco F, Rotondi M, Cioffi M, Tuccillo C, Sorvillo F, Caporaso N, Amato G. Eur J Endocrinol; 2002 Jun; 146(6):743-9. PubMed ID: 12039693 [Abstract] [Full Text] [Related]
26. Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin. Antonini MG, Babudieri S, Maida I, Baiguera C, Zanini B, Fenu L, Dettori G, Manno D, Mura MS, Carosi G, Puoti M. Infection; 2008 Jun; 36(3):250-5. PubMed ID: 18458815 [Abstract] [Full Text] [Related]
27. Mania during treatment of chronic hepatitis C with pegylated interferon and ribavirin. Onyike CU, Bonner JO, Lyketsos CG, Treisman GJ. Am J Psychiatry; 2004 Mar; 161(3):429-35. PubMed ID: 14992966 [No Abstract] [Full Text] [Related]
28. [Early virologic response in retherapy with pegylated interferon alpha-2B plus ribavirin in children with chronic hepatitis C]. Pawłowska M, Palewicz E, Halota W. Przegl Epidemiol; 2006 Mar; 60(1):71-7. PubMed ID: 16758742 [Abstract] [Full Text] [Related]
29. Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890. Hézode C, Fontaine H, Dorival C, Larrey D, Zoulim F, Canva V, de Ledinghen V, Poynard T, Samuel D, Bourlière M, Zarski JP, Raabe JJ, Alric L, Marcellin P, Riachi G, Bernard PH, Loustaud-Ratti V, Métivier S, Tran A, Serfaty L, Abergel A, Causse X, Di Martino V, Guyader D, Lucidarme D, Grando-Lemaire V, Hillon P, Feray C, Dao T, Cacoub P, Rosa I, Attali P, Petrov-Sanchez V, Barthe Y, Pawlotsky JM, Pol S, Carrat F, Bronowicki JP, CUPIC Study Group. J Hepatol; 2013 Sep; 59(3):434-41. PubMed ID: 23669289 [Abstract] [Full Text] [Related]
34. Interferon-alpha-2B and ribavirin in combination for chronic hepatitis C patients not responding to interferon-alpha alone: an Italian multicenter, randomized, controlled, clinical study. Barbaro G, Di Lorenzo G, Soldini M, Giancaspro G, Bellomo G, Belloni G, Grisorio B, Annese M, Bacca D, Francavilla R, Rizzo G, Barbarini G. Am J Gastroenterol; 1998 Dec; 93(12):2445-51. PubMed ID: 9860407 [Abstract] [Full Text] [Related]